A. PELLERIN ET AL: "Anti-BDCA2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms", EMBO MOLECULAR MEDICINE, vol. 7, no. 4, 1 April 2015 (2015-04-01), pages 464-476, XP055225280, Weinheim ISSN: 1757-4676, DOI: 10.15252/emmm.201404719 (B1)

BLOMBERG S ET AL: "Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus", ARTHRITIS & RHEUMATISM, J.B. LIPPINCOTT CO, vol. 48, no. 9, 1 September 2003 (2003-09-01), pages 2524-32, XP002991721, ISSN: 0004-3591, DOI: 10.1002/ART.11225 (B1)

Cristina Caldas ET AL: "Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen.", Molecular immunology, vol. 39, no. 15, 1 May 2003 (2003-05-01), pages 941-952, XP055025334, ISSN: 0161-5890, DOI: 10.1016/S0161-5890(03)00022-1 (B1)

DZIONEK A ET AL: "BDCA-2, BDCA-3, AND BDCA-4: THREE MARKERS FOR DISTINCT SUBSETS OF DENDRITIC CELLS IN HUMAN PERIPHERAL BLOOD", IMMUNOLOGY, BLACKWELL PUBLISHING, OXFORD, GB, vol. 165, no. 11, 1 December 2000 (2000-12-01), pages 6037-6046, XP000986292, ISSN: 0019-2805 (B1)

DZIONEK A ET AL: "BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 194, no. 12, 17 December 2001 (2001-12-17), pages 1823-1834, XP002277387, ISSN: 0022-1007, DOI: 10.1084/JEM.194.12.1823 (B1)

WU P ET AL: "TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients", CLINICAL IMMUNOLOGY, ACADEMIC PRESS, US, vol. 129, no. 1, 1 October 2008 (2008-10-01), pages 40-48, XP025408487, ISSN: 1521-6616, DOI: 10.1016/J.CLIM.2008.06.004 [retrieved on 2008-08-05] (B1)

JAHN P S ET AL: "BDCA-2 signaling inhibits TLR-9-agonist-induced plasmacytoid dendritic cell activation and antigen presentation", CELLULAR IMMUNOLOGY, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 265, no. 1, 1 January 2010 (2010-01-01), pages 15-22, XP027236570, ISSN: 0008-8749 [retrieved on 2010-07-06] (B1)

NESTLE F O ET AL: "Plasmocytoid predendritic cells initiate psoriasis through interferon-alpha production", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, vol. 202, no. 1, 4 July 2005 (2005-07-04), pages 135-143, XP002364226, ISSN: 0022-1007, DOI: 10.1084/JEM.20050500 (B1)

RIBOLDI E ET AL: "Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells", IMMUNOBIOLOGY, URBAN UND FISCHER VERLAG, DE, vol. 214, no. 9-10, 1 September 2009 (2009-09-01), pages 868-876, XP026467210, ISSN: 0171-2985, DOI: 10.1016/J.IMBIO.2009.06.016 [retrieved on 2009-07-04] (B1)

WEI CAO ET AL: "BDCA2/FcɛRI[gamma] Complex Signals through a Novel BCR-Like Pathway in Human Plasmacytoid Dendritic Cells", PLOS BIOLOGY, vol. 100, no. 10, 1 January 2007 (2007-01-01), page 183, XP055105679, ISSN: 1091-6490, DOI: 1091-6490(2003)100[0183:IHIIHT]2.0.CO;2 (B1)

WO-A2-01/36487 (B1)

J. Röck ET AL: "CD303 (BDCA-2) signals in plasmacytoid dendritic cells via a BCR-like signalosome involving Syk, Slp65 and PLCc2", European Journal of Immunology, vol. 37, no. 12, 1 December 2007 (2007-12-01), pages 3564-3575, XP055225344, DOI: 10.1002/eji.200737711 (B1)